[1] ZENG C, CHEN LL,YANG Z, et al. The close correlation between heparanase and COX-2 expression in lymphangiogenesis of cervical cancer[J]. Med Oncol,2014,31(12):314. [2] ZHANG L X, NGO J A, WETZEL M D, et al. Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer[J].Neoplasia, 2015, 17(1):101-113. [3] LI H L, GU J, WU J J, et al. Heparanase mRNA and protein expression correlates with clinicopathologic features of gastric cancer patients: A Meta-analysis[J]. Asian Pac J Cancer Prev, 2015, 16(18): 8653-8658. [4] 杨其容,张平安. 肝癌组织乙酰肝素酶的表达及其与微血管密度的关系[J].实用肝脏病杂志,2015,18(6):643-646. [5] 杨传家,宫建,吴锋,等.乙酰肝素酶与甲状腺乳头状癌淋巴结转移的相关性研究[J].广西医学,2015,22(1):45-47. [6] TANG D B,PIAO Y,ZHAO S,et al. Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer [J].Med Oncol,2014,31(7):26. [7] HU B,WANG Q,SHI Y Y,et al.Significance of heparanase in metastatic lymph nodes of cervical squamous cell cancer[J].Oncol Lett,2017,13(5):3219-3224. [8] JIN H,CUI M. Gene silencing of heparanase results in suppression of invasion and migration of gallbladder carcinoma cells[J]. Biosci Biotechnol Biochem,2018,82(7):1116-1122. [9] PISANO C,VLODAVSKY I,ILAN N,et al.The potential of heparanase as a therapeutic target in cancer [J].Biochem Pharmacol,2014,89(1):12-19. [10] MASOLA V, SECCHI M F,GAMBARO G,et al.Heparanase as a target in cancer therapy[J].Curr Cancer Drug Targets,2014,14( 3): 286-293. [11] VLODAVSKY I,BECKHOVE P,LERNER I,et al. Significance of heparanase in cancer and inflammation[J]. CancerMicroenviron,2012,5(2):115-132. [12] 吕帅,王艳林,刘彦廷,等. 整合素αvβ3拮抗剂HYPOO23对耐药神经胶质瘤细胞U251凋亡的影响[J].实用医学杂志,2018, 34(7):1089-1091. [13] 王闯,王明娟,王一帆,等. 宫颈鳞癌整合素α5β1蛋白和乙酰肝素酶蛋白的表达及生物学行为[J].中国老年学杂志,2016, 36(13):3131-3133. [14] CHI F S,FU D,ZHANG X P,et al.Expression of the c-met proto-oncogene and integrin α5β1 in human gastric cardia adenocarcinoma [J].Biosci Biotechnol Biochem,2012,76(8): 1471-1476. [15] TOQUET C,COLSON A,JARRY A,et al.ADAM15 to α5β1 integrin switch in colon carcinoma cells: A late event in cancer progression associated with tumor dedifferentiation and poor prognosis[J].Int J Cancer,2012,130(2):278-287. [16] SHAO S, ZHT Y, MENG T,et al. Targeting high expressed α5β1 integrin in liver metastatic lesions to resist metastasis of colorectal cancer by RPM peptide-modified chitosan-stearic micelles[J]. Mol Pharm,2018,15(4):1653-1663. [17] RENNER G,NOULET F,MERCIER M C,et al. Expression/activation of α5β1 integrin is linked to the β-catenin signalingpathway to drive migration in glioma cells[J].Oncotarget,2016,7(38):62194-62207. [18] KOZLOVA N I, MOROZEVICH G E, USHAKOVA N A, et al.Implication of integrin alpha5beta1 signal pathways in proliferation and apoptosis of MCF-7/Dox human breast carcinoma cells[J]. Biomed Khim,2016, 62(3):272-278. [19] MITRA A K,SAWADA K,TIWARI P,et al. Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulatesovarian cancer invasion and metastasis[J].Oncogene,2011,30(13):1566-1576. [20] 徐律韵,朱从健,陈洪. 整合素α5β1与肿瘤发生、发展相关性的研究进展[J].临床肿瘤学杂志,2014,19(1):86-89. |